Changes

No change in size ,  06:49, 2 June 2021
Line 94: Line 94:  
|+ Table 1: [[Dhatu]] specific rasayana herbs  
 
|+ Table 1: [[Dhatu]] specific rasayana herbs  
 
|-
 
|-
! Body tissues ([[dhatu]]s) !! Rasyana herbs<ref name=joshiks>Joshi KS, Bhonde R. Insights from Ayurveda for translational stem cell research. J Ayurveda Integr Med 2014;5:4-10</ref>  
+
! Body tissues ([[dhatu]]s) !! Rasyana herbs<ref name=joshiks>Joshi KS, Bhonde R. Insights from Ayurveda for translational stem cell research. J Ayurveda Integr Med 2014;5:4-10</ref>  
 
|-
 
|-
 
| | Nourishing fluid ([[rasa dhatu]])  ||  Tinospora cordifolia
 
| | Nourishing fluid ([[rasa dhatu]])  ||  Tinospora cordifolia
Line 243: Line 243:  
Administration of tuvaraka rasayana (rasayana preparation made out of Hydnocarpus laurifolia) alternatively for 5 days in a patient with psoriasis vulgaris showed reduction in PASI score from 42 to 3.8. The rasayana was administered after purification procedures. Complete remission of the lesions making PASI score 0 was observed. The histopathological study also reveals the complete remission of psoriasis on follow-up.<ref name=krishnakumar>Krishna Kumar K, Chacko J. Thuvaraka rasayana regimen in Psoriasis vulgaris - A case report. J Ayurveda Integr Med. 2019 Jan-Mar;10(1):41-44. doi: 10.1016/j.jaim.2018.04.003. Epub 2019 Jan 1. PMID: 30606464; PMCID: PMC6470303.</ref>
 
Administration of tuvaraka rasayana (rasayana preparation made out of Hydnocarpus laurifolia) alternatively for 5 days in a patient with psoriasis vulgaris showed reduction in PASI score from 42 to 3.8. The rasayana was administered after purification procedures. Complete remission of the lesions making PASI score 0 was observed. The histopathological study also reveals the complete remission of psoriasis on follow-up.<ref name=krishnakumar>Krishna Kumar K, Chacko J. Thuvaraka rasayana regimen in Psoriasis vulgaris - A case report. J Ayurveda Integr Med. 2019 Jan-Mar;10(1):41-44. doi: 10.1016/j.jaim.2018.04.003. Epub 2019 Jan 1. PMID: 30606464; PMCID: PMC6470303.</ref>
   −
====Triphalarasayana====
+
====Triphala rasayana====
 
   
 
   
 
Pre-treatment of mice with rasayana drug, triphala (Haritaki, vibitaki and amalaki) extract for 7 days showed protection against paracetamol-induced renal and hepatic toxicity. Triphala inhibited the raise of serum enzyme markers like ASP, ALP, ALT, bilirubin, creatinine, urea and uric acid. Histopathological study reveals protection of liver cells, central vein, and portal vein and maintains the normality of liver tissues. Triphala might have controlled the free radical formation and thereby prevents cellular damage.<ref>Singh DP, Mani D. Protective effect of Triphala Rasayana against paracetamol-induced hepato–renal toxicity in mice. J Ayurveda Integr Med 2015;6:181-6.</ref>
 
Pre-treatment of mice with rasayana drug, triphala (Haritaki, vibitaki and amalaki) extract for 7 days showed protection against paracetamol-induced renal and hepatic toxicity. Triphala inhibited the raise of serum enzyme markers like ASP, ALP, ALT, bilirubin, creatinine, urea and uric acid. Histopathological study reveals protection of liver cells, central vein, and portal vein and maintains the normality of liver tissues. Triphala might have controlled the free radical formation and thereby prevents cellular damage.<ref>Singh DP, Mani D. Protective effect of Triphala Rasayana against paracetamol-induced hepato–renal toxicity in mice. J Ayurveda Integr Med 2015;6:181-6.</ref>
2,062

edits